Jeff Heiser

Company: BA Sciences’

Job title: Chief Scientific Officer of Microbial and Advanced Therapeutic Platforms

Seminars:

Implementation of Phase Appropriate mRNA Analytics in a Contract Testing Environment: Balancing the Development & Qualification Approaching a mRNA Program 1:00 pm

The analytical requirements for characterization of mRNA Drug Substance and Drug Products have been defined by the USP as well as sponsor companies participating in early phase clinical trials Balancing the effort spent on method development and qualification/validation is critical to keeping with timelines and controlling analytical costs How to utilize a suite of mRNA…Read more

day: Conference Day One